Stocks and Investing Stocks and Investing
Mon, March 3, 2014
Fri, February 28, 2014
Thu, February 27, 2014
Wed, February 26, 2014
Tue, February 25, 2014
Mon, February 24, 2014
Fri, February 21, 2014
Thu, February 20, 2014
Wed, February 19, 2014
Tue, February 18, 2014
Mon, February 17, 2014
Fri, February 14, 2014
Thu, February 13, 2014
Wed, February 12, 2014
Tue, February 11, 2014
Mon, February 10, 2014
Fri, February 7, 2014
Thu, February 6, 2014
Wed, February 5, 2014
Tue, February 4, 2014
Mon, February 3, 2014
Fri, January 31, 2014
Thu, January 30, 2014
Wed, January 29, 2014
Tue, January 28, 2014

Liav Abraham Maintained (TEVA) at Strong Buy with Increased Target to $50 on, Jan 28th, 2014


Published on 2024-10-25 04:09:31 - WOPRAI, Liav Abraham
  Print publication without navigation


Liav Abraham of Citigroup, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $47 to $50 on, Jan 28th, 2014.

Liav has made no other calls on TEVA in the last 4 months.



There are 2 other peers that have a rating on TEVA. Out of the 2 peers that are also analyzing TEVA, 1 agrees with Liav's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014


This is the rating of the analyst that currently disagrees with Liav


  • Chris Schott of "JP Morgan" Downgraded from Hold to Sell and Decreased Target to $38 on, Monday, November 4th, 2013